Like many other site organizations, DaVita Clinical Research has struggled with defining ourselves within an industry that holds firm to their acronyms. CRO, or contract research organization, has been able… Read more
The Guideline for Good Clinical Practice (GCP) is a set of guidelines written by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). These guidelines… Read more
The DaVita Clinical Research (DCR) Biorepository Grant Program (BioReG) was formed support precision-based medicine innovation in nephrology. To see an update of the BioReG Gran Program, please click the… Read more
Chances are that you or someone you know has faced a cancer diagnosis. It’s also likely that after a diagnosis, the possibility of participating in clinical trials was highlighted. For… Read more
Patient enrollment for clinical trials can be a challenging task especially if the patients are dealing with a chronic illness. Dialysis patients in particular are a population that need a… Read more
Over the next few years, the patents for many therapeutic biologics will expire, allowing drug manufacturers to request US Food and Drug Administration (FDA) approval for biosimilars, medical products which… Read more
New study sheds light on the factors for high turnover of principal investigators in FDA-regulated clinical trials. The U.S. biopharmaceutical industry is a global leader in the development of innovative… Read more
Sometimes you experience great service. An interaction that leaves you thinking – WOW, that person really loves their job! A problem you had solved in a way that left you… Read more
Informed consent to participation in a clinical trial involves substantially more than obtaining signatures from subjects on a written form. It includes providing to potential participants enough information about the… Read more
A common trend in the drug development industry is to utilize data and innovation to safely begin participant involvement earlier and earlier in clinical trials. As innovation continues to be… Read more